Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study
Audran, R., Chtioui, H., Thierry, A. C., Mayor, C. E., Vallotton, L., Dao, K., Rothuizen, L. E., Maghraoui, A., Pennella, E. J., Brunner-Ferber, F., Buclin, T., Spertini, F.
Published in Scientific reports (04.06.2024)
Published in Scientific reports (04.06.2024)
Get full text
Journal Article
Prospective observational comparison of outcomes in African American and Caucasian patients receiving second-line treatment with pemetrexed for advanced non-small cell lung cancer (NSCLC)
Pennella, E. J., Pohl, G., Girvan, A. C., Winfree, K., Martinez, B., Obasaju, C. K., Walker, M. S., Stepanski, E. J., Schwartzberg, L. S., Adjei, A. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Brain metastases (BM) as the primary site of relapse in two randomized phase III pemetrexed (P) trials in advanced non-small cell lung cancer (NSCLC)
Ortuzar, W. F., Pennella, E. J., John, W. J., Simms, L., Peng, G., Treat, J., Obasaju, C. K.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Interim results of an observational study evaluating the impact of ethnic origin on the effect of second-line treatment with pemetrexed (P) for advanced non-small cell lung cancer (NSCLC)
Pennella, E. J., Peltz, G., Girvan, A. C., Pohl, G., Faries, D. E., Marciniak, M. D., Obasaju, C. K., Stepanski, E. J., Schwartzberg, L., Adjei, A. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article